Healthcare -
Biotechnology - NASDAQ - US
$ 3.86
-3.5 %
$ 165 M
Market Cap
-6.43
P/E
DMAC - REVENUE
Revenue DMAC - DiaMedica Therapeutics Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR